@PeterHall001

Oncologist interested in Data Science and Health Economics. Find me on https://xitter.cf/t.co/1DqiYxPchS

 Edinburgh, Scotland
ed.ac.uk/profile/peter-hall
Joined November 2009
  • Tweets2K
  • Following595
  • Followers746
18Media
Variation in chemotherapy prescribing rates and mortality in early breast cancer in Scotland. A national data linkage study - variation is reducing over the last 20 yrs @CancerDataEdin sciencedirect.com/science/ar…
1
1
5
Edinburgh Breast Cancer Specialist Symposium 2025 (EBCSS) 21-22 Feb was a great success. Excellent scientific programme, eminent speakers, brilliant talks and superb organisation. Hope to see you all again in Feb 2027
3
19
709
Annual versus less frequent mammographic surveillance in people with breast cancer aged 50 years and older in the UK (Mammo-50): a multicentre, randomised, phase 3, non-inferiority trial - The Lancet thelancet.com/journals/lance…

Annual versus less frequent mammographic surveillance in people with breast cancer aged 50 years...

For patients aged 50 years or older and at 3 years post diagnosis, less frequent mammograms were non-inferior compared with annual mammograms for breast cancer-specific survival, recurrence-free...

thelancet.com
85
#SABCS24 FDA session highlighting need to consider Minimum Effictive Dose, not just Maximum Tolerated Dose. Reminds me of the GO2 trial last decade. Breast cancer drug development catching up? jamanetwork.com/journals/jam…

Efficacy of Reduced-Intensity Chemotherapy Among Older and Frail Patients With Advanced Gastroeso...

This randomized clinical trial assesses the efficacy of reduced-intensity chemotherapy for patient quality of life and cancer control in the treatment of older and/or frail patients.

jamanetwork.com
94
Find me on bsky.app/profile/peterhall00…
53
RCT of the effect of the omega-3 polyunsaturated fatty acid EPA on colorectal cancer recurrence and survival after surgery for resectable liver metastases: EPA for Metastasis Trial 2 (EMT2) study protocol bmjopen.bmj.com/content/13/1…

Randomised, placebo-controlled, phase 3 trial of the effect of the omega-3 polyunsaturated fatty...

Introduction There remains an unmet need for safe and cost-effective adjunctive treatment of advanced colorectal cancer (CRC). The omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) is...

bmjopen.bmj.com
220
Having a break from Twitter
1
334
Edinburgh Pain Assessment Tool EPAT results in prescription of less opioids but more adjuvant analgesics and non-pharmacological approaches. Reduces costs overall. spcare.bmj.com/cgi/rapidpdf/…
1
3
5
1,135
@KDiernberger
209
Excellent EBCSS 2023 meeting yesterday. Most well organised meeting with the best programme. Heartiest congratulations to the organising committee.
7
26
1,776
Great to see this out. First data from the SCCAMP study - we looked at COVID infection and vaccination status of patients with solid organ cancers undergoing active cancer treatment from the beginning of the pandemic, with longitudinal antibody serology doi.org/10.1093/oncolo/oyac2…

The Scottish COVID Cancer Immunity Prevalence Study: A Longitudinal Study of SARS-CoV-2 Immune...

This article characterizes the incidence and outcomes of SARS-CoV-2 infection and vaccination in patients with solid tumors undergoing anti-cancer treatmen

academic.oup.com
1
7
1
23
3,735
Check it out! 👆👆👆Real world ongoing study that we are excited to build upon. Truly collaborative, supported by @EdinCRC @NHS_Lothian and an @EcatTrack collab in there too. @PeterHall001
1
5
428
If interested in #PancreaticCancer, #AI and #DataScience, please apply to join our team @precisionpanc @UofGCancerSci @CRUKScotland @EdinCRC @PeterHall001 👇 findaphd.com/phds/project/fu…

FULLY FUNDED PROJECT - Identifying the histomorphological features and molecular drivers of...

PhD Project - FULLY FUNDED PROJECT - Identifying the histomorphological features and molecular drivers of pancreatic cancer progression at University of Glasgow, listed on FindAPhD.com

findaphd.com
9
2
12
4,542
Real-World Impact of SABR on Stage I Non-Small-Cell Lung Cancer Outcomes at a Scottish Cancer Centre mdpi.com/2157404 #mdpicancers via @Cancers_MDPI

Real-World Impact of SABR on Stage I Non-Small-Cell Lung Cancer Outcomes at a Scottish Cancer Centre

Introduction: Stereotactic ablative body radiotherapy (SABR) offers patients with stage I non-small-cell lung cancer (NSCLC) a safe, effective radical therapy option. The impact of introducing SABR...

mdpi.com
1
237
“The Scottish COVID Cancer Immunity Prevalence Study: A Longitudinal Study of SARS-CoV-2 Immune Response in Patients Receiving Anti–Cancer Treatment” - work by @EdinCRC @EdinUni_IGC @CancerDataEdin investigators and colleagues published in @OncJournal 👇. doi.org/10.1093/oncolo/oyac2…

The Scottish COVID Cancer Immunity Prevalence Study: A Longitudinal Study of SARS-CoV-2 Immune...

This article characterizes the incidence and outcomes of SARS-CoV-2 infection and vaccination in patients with solid tumors undergoing anti-cancer treatmen

academic.oup.com
5
1
3
1,607
Peter Hall retweeted
Riinu Pius@_Riinu_1 Dec 2022
🌟Day 01 - Summarising factors with finalfit🌟 #HealthyR #rstats: excerpts from our "R for Health Data Science" book! Comment: when did you last use summary_factorlist()? Any questions: @ewenharrison and myself happy to answer here! Book chapter here: argoshare.is.ed.ac.uk/health…
library(finalfit) meldata %>% summary_factorlist(dependent = "status_dss", explanatory = "ulcer.factor")

ALT library(finalfit) meldata %>% summary_factorlist(dependent = "status_dss", explanatory = "ulcer.factor")

1
8
1
21
The protocol for our @HDR_UK project "Studying the Long term Impact of COVID in Kids" (SLICK) is now out in @BMJ_Open Brilliant team looking at healthcare use in the year after SARS-CoV-2 infection in children across the UK bmjopen.bmj.com/content/12/1…
3
15
2
35
Reproductive history differs by molecular subtypes of breast cancer among women aged ≤ 50 years in Scotland diagnosed 2009–2016: a cross-sectional study link.springer.com/article/10…

Reproductive history differs by molecular subtypes of breast cancer among women aged ≤ 50 years in...

Breast Cancer Research and Treatment - The aetiology of breast cancers diagnosed ≤ 50 years of age remains unclear. We aimed to compare reproductive risk factors between...

link.springer.com
1
1
Look out for us at Scottish Health Economics! @PeterHall001 @ElizabethLemm @bullen_ali & our fresh faced new starter Marek Atter are all attending in person!
3
9
Exciting to see scientists from the Glasgow Beatson Institute joining fellow Cancer Research UK colleagues in Edinburgh as part of the new CRUK Scotland Centre - looking forward to new inspiring collaborations @owen_sansom @CRUK_BI @UofGlasgow @EdinburghUni @EdinUni_IGC
L-R Professor Owen Sansom, Director Beatson Institute and Professor Charlie Gourley Clinical Director, both of the CRUK Scotland Centre.

ALT L-R Professor Owen Sansom, Director Beatson Institute and Professor Charlie Gourley Clinical Director, both of the CRUK Scotland Centre.

19
1
90
DATA-CAN partner organisations NHS Lothian and the University of Edinburgh have developed DataLoch, a new secure and pioneering data service which will enable improvements in health and social care in Scotland and across the UK. data-can.org.uk/news-item/da…

DataLoch – the full launch and opportunities for cancer research - DATA-CAN

DATA-CAN partner organisations NHS Lothian and the University of Edinburgh have developed DataLoch, a new secure and pioneering data service which will enable improvements in health and social care...

data-can.org.uk
4
1
6
Load more